Skip to main content
OSE Immunotherapeutics SA (EPA:OSE)
France flag France · Delayed Price · Currency is EUR
3.914
-0.104 (-2.59%)
Mar 9, 2026, 5:35 PM CET

OSE Immunotherapeutics Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-32.5237.45-23-17.76-16.85
Upgrade
Depreciation & Amortization
1.210.953.533.542.66
Upgrade
Other Amortization
-2.36---
Upgrade
Stock-Based Compensation
-2.091.752.732.94
Upgrade
Other Operating Activities
2.236.24-0.98-3.380.64
Upgrade
Change in Accounts Receivable
--3.16-0.58--
Upgrade
Change in Accounts Payable
--1.570.76--
Upgrade
Change in Income Taxes
--2.62-0.22-0.24-0.33
Upgrade
Change in Other Net Operating Assets
2.496.71-1.02-3.141.03
Upgrade
Operating Cash Flow
-26.648.44-19.76-18.25-9.92
Upgrade
Capital Expenditures
-0.45-0.08-0.02-0.27-0.47
Upgrade
Investment in Securities
--46.83-0.28--
Upgrade
Other Investing Activities
36.11--0.220.3-0.36
Upgrade
Investing Cash Flow
35.66-46.91-0.510.03-0.83
Upgrade
Long-Term Debt Issued
-2.115.0212.0615.28
Upgrade
Long-Term Debt Repaid
-7.2-6.25-3.36-1.8-0.59
Upgrade
Net Debt Issued (Repaid)
-7.2-4.151.6710.2614.69
Upgrade
Issuance of Common Stock
-1.1611.66-0.27
Upgrade
Other Financing Activities
-0.6-0.47-0.01-
Upgrade
Financing Cash Flow
-7.79-3.4613.3210.2714.96
Upgrade
Miscellaneous Cash Flow Adjustments
---0--
Upgrade
Net Cash Flow
1.27-1.93-6.95-7.964.21
Upgrade
Free Cash Flow
-27.0548.36-19.78-18.53-10.39
Upgrade
Free Cash Flow Margin
-1518.01%57.97%-888.19%-101.22%-39.50%
Upgrade
Free Cash Flow Per Share
-1.231.89-1.01-1.00-0.57
Upgrade
Cash Interest Paid
-0.47---
Upgrade
Levered Free Cash Flow
-16.7133.19-11.18-9.07-4.21
Upgrade
Unlevered Free Cash Flow
-16.7135.17-9.8-8.21-3.69
Upgrade
Change in Working Capital
2.49-0.64-1.05-3.380.69
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.